Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Asset Utilization Ratio (2016 - 2021)

Historic Asset Utilization Ratio for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to 0.54.

  • Neurocrine Biosciences' Asset Utilization Ratio fell 2205.58% to 0.54 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.54, marking a year-over-year decrease of 2205.58%. This contributed to the annual value of 0.69 for FY2020, which is 34.66% up from last year.
  • Neurocrine Biosciences' Asset Utilization Ratio amounted to 0.54 in Q3 2021, which was down 2205.58% from 0.54 recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Asset Utilization Ratio peaked at 0.7 during Q2 2020, and registered a low of 0.01 during Q2 2017.
  • For the 5-year period, Neurocrine Biosciences' Asset Utilization Ratio averaged around 0.48, with its median value being 0.54 (2021).
  • Per our database at Business Quant, Neurocrine Biosciences' Asset Utilization Ratio crashed by 6401.11% in 2017 and then surged by 313172.55% in 2018.
  • Neurocrine Biosciences' Asset Utilization Ratio (Quarter) stood at 0.2 in 2017, then soared by 130.39% to 0.47 in 2018, then soared by 35.38% to 0.63 in 2019, then increased by 1.91% to 0.65 in 2020, then decreased by 16.7% to 0.54 in 2021.
  • Its Asset Utilization Ratio was 0.54 in Q3 2021, compared to 0.54 in Q2 2021 and 0.58 in Q1 2021.